XML 50 R55.htm IDEA: XBRL DOCUMENT v3.20.1
Share-based Compensation - Plan Information (Details) - shares
3 Months Ended 12 Months Ended 57 Months Ended
Jan. 01, 2020
Jan. 01, 2019
Jun. 27, 2018
Jul. 30, 2017
Mar. 31, 2020
Dec. 31, 2019
Mar. 31, 2020
Jan. 01, 2016
Jul. 31, 2015
Nov. 30, 2009
Stock options outstanding | Performance based                    
Stock options, restricted stock and performance stock options                    
Vesting period         3 years          
Stock options                    
Stock options, restricted stock and performance stock options                    
Options granted (in shares)         1,897,250 2,119,708        
Expired, forfeited or cancelled (in shares)         (221,513)          
Stock options | Minimum                    
Stock options, restricted stock and performance stock options                    
Vesting period         2 years          
Stock options | Maximum                    
Stock options, restricted stock and performance stock options                    
Vesting period         4 years          
Neos Therapeutics, Inc. 2009 Equity Plan                    
Stock options, restricted stock and performance stock options                    
Shares reserved for issuance under the plan                   1,375,037
Neos Therapeutics, Inc. 2009 Equity Plan | Stock options                    
Stock options, restricted stock and performance stock options                    
Expiration period         10 years          
Expiration period of unexercised vested award after termination of employment         90 days          
Neos Therapeutics, Inc. 2009 Equity Plan | Restricted stock | Minimum                    
Stock options, restricted stock and performance stock options                    
Vesting period         1 month          
Neos Therapeutics, Inc. 2009 Equity Plan | Restricted stock | Maximum                    
Stock options, restricted stock and performance stock options                    
Vesting period         48 months          
Neos Therapeutics, Inc. 2015 Stock Option and Incentive Plan                    
Stock options, restricted stock and performance stock options                    
Shares reserved for issuance under the plan                 767,330  
Increase to the number of shares reserved and available for issuance as a percentage of outstanding common stock (as a percent)               5.00%    
Increase in number of shares reserved and available for issuance 2,486,633 2,483,815                
Stock option exercise price, minimum expressed as percentage of fair market value on grant date         100.00%          
Shares related to forfeited prior plan options transferred into shares available under current plan         6,247   440,111      
Shares reserved and available for issuance         3,226,745   3,226,745      
Neos Therapeutics, Inc. 2015 Stock Option and Incentive Plan | Stock options                    
Stock options, restricted stock and performance stock options                    
Expiration period         10 years          
Expiration period of unexercised vested award after termination of employment         90 days          
Options granted (in shares)         1,897,250          
Neos Therapeutics, Inc 2018 Inducement Plan                    
Stock options, restricted stock and performance stock options                    
Shares reserved for issuance under the plan         800,000   800,000      
Stock option exercise price, minimum expressed as percentage of fair market value on grant date         100.00%          
Shares reserved and available for issuance         100,000   100,000      
Neos Therapeutics, Inc 2018 Inducement Plan | Stock options                    
Stock options, restricted stock and performance stock options                    
Expiration period         10 years          
Expired, forfeited or cancelled (in shares)         (100,000)          
Neos Therapeutics, Inc 2018 Inducement Plan | Stock options | Chief Executive Officer                    
Stock options, restricted stock and performance stock options                    
Vested shares of the common stock subject to the option vests in equal installments over four years (in shares)     600,000              
Options granted (in shares)       200,000